Summary & Overview
CPT 41155: Radical Tongue and Mandible Resection with Unilateral Neck Dissection
CPT code 41155 represents a major head and neck oncologic resection that removes all or part of the tongue, part of the mandible, the floor of mouth tissues, and includes unilateral neck dissection for lymphadenectomy. Nationally, this code denotes high-complexity surgical care typically performed for oral cavity cancers and is associated with hospital-based operative and inpatient services. Payers commonly engaged in coverage and reimbursement decisions for this procedure include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical scope captured by CPT code 41155, the typical site and setting of service, and the payer landscape relevant to reimbursement and coverage discussions. The publication provides benchmarks and policy context for hospital and surgical service lines, highlights clinical considerations tied to major head and neck oncologic surgery, and flags areas where supplemental documentation and coding specificity can affect payment. Data not available in the input are noted where applicable. This overview is intended for a national audience including coding professionals, hospital administrators, and policy analysts.
Billing Code Overview
CPT code 41155 describes a radical surgical procedure that removes all or part of the tongue (glossectomy), includes resection of part of the mandible (jaw bone) and the tissue of the floor of the mouth, and incorporates removal of lymph nodes and other tissues from one side of the neck. This procedure is most often used to treat oral cavity cancer.
-
Service type: Major head and neck oncologic resection with unilateral neck dissection
-
Typical site of service: Hospital operating room, often with inpatient postoperative admission
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with a history of heavy tobacco and alcohol use presents with a progressively enlarging, ulcerated mass of the lateral oral tongue with induration of the adjacent floor of mouth and clinical fixation to the mandible. Imaging (contrast-enhanced CT and MRI) demonstrates a primary tumor involving the anterior two-thirds of the tongue with cortical erosion of the ipsilateral mandibular body and radiographic suspicious ipsilateral level I–III lymphadenopathy. Biopsy confirms squamous cell carcinoma of the tongue. The multidisciplinary head and neck tumor board recommends primary surgical management with hemiglossectomy, ipsilateral segmental mandibulectomy (through both intraoral and extraoral approaches), and unilateral selective neck dissection. Preoperative workflow includes anesthesia evaluation, dental/oral surgery consult for mandibular reconstruction planning, staging imaging, and consent for possible tracheostomy and free flap reconstruction. Intraoperatively, the surgeon performs resection of the involved portion of the tongue and mandible, wide local excision of the floor of mouth tissues, and removal of ipsilateral cervical lymph nodes. Postoperative care includes airway monitoring (possible short-term tracheostomy), flap monitoring if reconstruction performed, pathology-directed adjuvant therapy planning, and coordination with medical and radiation oncology for adjuvant treatment as indicated by margins and nodal status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |